These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 34433060)
1. Stabilization of Motin family proteins in NF2-deficient cells prevents full activation of YAP/TAZ and rapid tumorigenesis. Wang Y; Zhu Y; Gu Y; Ma M; Wang Y; Qi S; Zeng Y; Zhu R; Wang X; Yu P; Xu J; Shu Y; Yu FX Cell Rep; 2021 Aug; 36(8):109596. PubMed ID: 34433060 [TBL] [Abstract][Full Text] [Related]
2. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369 [TBL] [Abstract][Full Text] [Related]
3. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers. Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856 [TBL] [Abstract][Full Text] [Related]
4. HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity. Yuan B; Liu J; Shi A; Cao J; Yu Y; Zhu Y; Zhang C; Qiu Y; Luo H; Shi J; Cao X; Xu P; Shen L; Liang T; Zhao B; Feng XH EMBO J; 2023 Feb; 42(4):e111549. PubMed ID: 36598329 [TBL] [Abstract][Full Text] [Related]
5. Two Hippo signaling modules orchestrate liver size and tumorigenesis. Qi S; Zhong Z; Zhu Y; Wang Y; Ma M; Wang Y; Liu X; Jin R; Jiao Z; Zhu R; Sha Z; Dang K; Liu Y; Lim DS; Mao J; Zhang L; Yu FX EMBO J; 2023 Jun; 42(11):e112126. PubMed ID: 36919851 [TBL] [Abstract][Full Text] [Related]
6. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells. White SM; Avantaggiati ML; Nemazanyy I; Di Poto C; Yang Y; Pende M; Gibney GT; Ressom HW; Field J; Atkins MB; Yi C Dev Cell; 2019 May; 49(3):425-443.e9. PubMed ID: 31063758 [TBL] [Abstract][Full Text] [Related]
7. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
8. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation. Wu Y; Qin K; Xu Y; Rajhans S; Vo T; Lopez KM; Liu J; Nipper MH; Deng J; Yin X; Ramjit LR; Ye Z; Luan Y; Arda HE; Wang P Elife; 2024 Jul; 13():. PubMed ID: 39051998 [TBL] [Abstract][Full Text] [Related]
9. Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass. Choi S; Kang JG; Tran YTH; Jeong SH; Park KY; Shin H; Kim YH; Park M; Nahmgoong H; Seol T; Jeon H; Kim Y; Park S; Kim HJ; Kim MS; Li X; Bou Sleiman M; Lee E; Choi J; Eisenbarth D; Lee SH; Cho S; Moore DD; Auwerx J; Kim IY; Kim JB; Park JE; Lim DS; Suh JM Nat Metab; 2024 May; 6(5):847-860. PubMed ID: 38811804 [TBL] [Abstract][Full Text] [Related]
10. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis. Li H; Gumbiner BM Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049 [TBL] [Abstract][Full Text] [Related]
11. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
12. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas. Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373 [TBL] [Abstract][Full Text] [Related]
13. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
14. Tolfenamic acid negatively regulates YAP and TAZ expression in human cancer cells. Kim I; Lertpatipanpong P; Yoon Y; Lee J; Hong Y; Boonruang K; Ryu J; Baek SJ Biochim Biophys Acta Mol Cell Res; 2023 Dec; 1870(8):119556. PubMed ID: 37544381 [TBL] [Abstract][Full Text] [Related]
15. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211 [TBL] [Abstract][Full Text] [Related]
16. The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer. Patterson MR; Cogan JA; Cassidy R; Theobald DA; Wang M; Scarth JA; Anene CA; Whitehouse A; Morgan EL; Macdonald A Nat Commun; 2024 Jul; 15(1):5809. PubMed ID: 38987584 [TBL] [Abstract][Full Text] [Related]
17. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Nishina H Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740 [TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762 [TBL] [Abstract][Full Text] [Related]
19. Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. Wu LMN; Deng Y; Wang J; Zhao C; Wang J; Rao R; Xu L; Zhou W; Choi K; Rizvi TA; Remke M; Rubin JB; Johnson RL; Carroll TJ; Stemmer-Rachamimov AO; Wu J; Zheng Y; Xin M; Ratner N; Lu QR Cancer Cell; 2018 Feb; 33(2):292-308.e7. PubMed ID: 29438698 [TBL] [Abstract][Full Text] [Related]
20. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis. Gill MK; Christova T; Zhang YY; Gregorieff A; Zhang L; Narimatsu M; Song S; Xiong S; Couzens AL; Tong J; Krieger JR; Moran MF; Zlotta AR; van der Kwast TH; Gingras AC; Sicheri F; Wrana JL; Attisano L Nat Commun; 2018 Aug; 9(1):3510. PubMed ID: 30158528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]